Market Overview:
The global neurorehabilitation market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of neurological disorders, rising awareness about neurorehabilitation, and technological advancements in the field of neurorehabilitation. Based on type, the global neurorehabilitation market is segmented into brain injury, spinal cord injury, peripheral nerve injury, and other types of neurological injuries. Brain injury is further segmented into traumatic brain injury (TBI) and stroke. Spinal cord injuries are classified into complete and incomplete spinal cord injuries. Peripheral nerve injuries are sub-segmented into upper extremity nerve damage and lower extremity nerve damage. Other types of neurological injuries include cerebral palsy, multiple sclerosis (MS), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Based on application, the global neurorehabilitation market is divided into general hospital settings rehabilitation units/centers; rehabilitation specialist hospitals; community-based rehabilitation centers; long-term care facilities; homecare settings; schools for children with special needs; vocational training institutes/centers for people with disabilities or chronic illnesses etc.).
Product Definition:
Neurorehabilitation is the rehabilitation of people with neurological disorders. It is an important part of treatment for many neurological conditions, including stroke, traumatic brain injury, and spinal cord injury. Neurorehabilitation may include physical therapy, occupational therapy, speech-language pathology, and cognitive rehabilitation.
Brain Injury:
The global brain injury market size was valued at USD 15.3 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of Traumatic Brain Injuries (TBIs) due to road accidents, falls, gunshot wounds, and violence is one of the major factors driving market growth globally.
Spinal Cord Injury:
Spinal cord injury (SCI) is a major neurological disorder that occurs when the spinal cord is injured due to trauma or disease. The primary symptoms of SCI include severe upper motor neuron damage and lower motor neuron damage.
According to the National Spinal Cord Injury Statistical Center, in 2016, there were 17,000 new cases of spinal cord injuries in the U.S., which resulted in an incidence rate of approximately 54 per million population annually.
Application Insights:
The general hospital segment dominated the market in 2017. This can be attributed to a large patient base and increasing number of neurorehabilitation centers. According to the Centers for Disease Control and Prevention (CDC), around 300,000 people suffer from spinal cord injuries every year making it one of the most common types of traumatic brain injuries. Moreover, according to data published by CDC in 2012, around 60% of all spinal cord injury cases occur among adults aged 30 years and above which is expected to boost demand over the forecast period.
The rehabilitation specialist hospital segment is expected register significant growth over the forecast period owing to an increase in patients suffering from neurological disorders coupled with rising need for specialized care services within hospitals or medical centers that offer comprehensive rehabilitation programs after a neurological injury has been sustained due largely on account of increased funding by government organizations such as National Institute on Disability (NID) & Rehabilitation Research & Training Centers (R&TCs).
Regional Analysis:
North America dominated the global market in 2017. Moreover, increasing government initiatives to create awareness about brain injury and other neurological disorders is also expected to drive the regional market during the forecast period. For instance, as part of its ongoing efforts to promote quality healthcare solutions that meet patients’ needs better than ever before throughout North America, NeuroPace received a grant from The Wyncote Foundation in 2016 for developing innovative technologies that enhance treatment outcomes for patients with TBI and PTSD.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising medical tourism activities supported by low costs associated with various treatments offered at private hospitals compared to those available at international hospitals in developed countries.
Growth Factors:
- Increasing incidence of neurological disorders: The global prevalence of neurological disorders is increasing at an alarming rate. This is primarily due to the aging population and the increased incidence of chronic diseases such as stroke, Alzheimer’s disease, and Parkinson’s disease. As a result, there is a growing demand for neurorehabilitation services.
- Advances in technology: Neurorehabilitation therapies are becoming more sophisticated with the advent of new technologies such as brain-computer interfaces (BCIs) and virtual reality (VR). These technologies are helping to improve the efficacy of neurorehabilitation treatments and provide better outcomes for patients.
- Growing awareness about neurorehabilitation: There is a growing awareness about the benefits of neurorehabilitation among both healthcare professionals and patients alike. This has led to an increase in demand for these services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurorehabilitation Market Research Report
By Type
Brain Injury, Spinal Cord Injury, Peripheral Nerve Injury, Other, Neurorehabilitatio
By Application
General Hospital, Rehabilitation Specialist Hospital, Community Rehabilitation Center
By Companies
VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH, Sun Java, Aoyang Health, PKUCare Rehabilitation Hospital, Beijing Puhua International Hospital, Xiangyu Medical, Beijing United Family Rehabilitation Hospital, Neurorehabilitatio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Neurorehabilitation Market Report Segments:
The global Neurorehabilitation market is segmented on the basis of:
Types
Brain Injury, Spinal Cord Injury, Peripheral Nerve Injury, Other, Neurorehabilitatio
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
General Hospital, Rehabilitation Specialist Hospital, Community Rehabilitation Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- VISHEE
- Beijing Bo'ai Hospital
- Beijing Rehabilitation Hospital of Capital Medical University
- NCC
- CHIEFTAIN
- Tongji Hospital
- Haobro Medical Device
- DIH
- Sun Java
- Aoyang Health
- PKUCare Rehabilitation Hospital
- Beijing Puhua International Hospital
- Xiangyu Medical
- Beijing United Family Rehabilitation Hospital
- Neurorehabilitatio
Highlights of The Neurorehabilitation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Brain Injury
- Spinal Cord Injury
- Peripheral Nerve Injury
- Other
- Neurorehabilitatio
- By Application:
- General Hospital
- Rehabilitation Specialist Hospital
- Community Rehabilitation Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurorehabilitation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neurorehabilitation is a treatment approach that helps people with neurological disorders such as stroke, spinal cord injury, and multiple sclerosis. It aims to improve the patient's ability to function independently and live a full life. Rehabilitation may include physical therapy, occupational therapy, speech therapy, and psychological counseling.
Some of the key players operating in the neurorehabilitation market are VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH, Sun Java, Aoyang Health, PKUCare Rehabilitation Hospital, Beijing Puhua International Hospital, Xiangyu Medical, Beijing United Family Rehabilitation Hospital, Neurorehabilitatio.
The neurorehabilitation market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurorehabilitation Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurorehabilitation Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurorehabilitation Market - Supply Chain
4.5. Global Neurorehabilitation Market Forecast
4.5.1. Neurorehabilitation Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurorehabilitation Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neurorehabilitation Market Absolute $ Opportunity
5. Global Neurorehabilitation Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neurorehabilitation Market Size and Volume Forecast by Type
5.3.1. Brain Injury
5.3.2. Spinal Cord Injury
5.3.3. Peripheral Nerve Injury
5.3.4. Other
5.3.5. Neurorehabilitatio
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neurorehabilitation Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neurorehabilitation Market Size and Volume Forecast by Application
6.3.1. General Hospital
6.3.2. Rehabilitation Specialist Hospital
6.3.3. Community Rehabilitation Center
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neurorehabilitation Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neurorehabilitation Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neurorehabilitation Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neurorehabilitation Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neurorehabilitation Demand Share Forecast, 2019-2026
9. North America Neurorehabilitation Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neurorehabilitation Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neurorehabilitation Market Size and Volume Forecast by Application
9.4.1. General Hospital
9.4.2. Rehabilitation Specialist Hospital
9.4.3. Community Rehabilitation Center
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neurorehabilitation Market Size and Volume Forecast by Type
9.7.1. Brain Injury
9.7.2. Spinal Cord Injury
9.7.3. Peripheral Nerve Injury
9.7.4. Other
9.7.5. Neurorehabilitatio
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neurorehabilitation Demand Share Forecast, 2019-2026
10. Latin America Neurorehabilitation Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neurorehabilitation Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neurorehabilitation Market Size and Volume Forecast by Application
10.4.1. General Hospital
10.4.2. Rehabilitation Specialist Hospital
10.4.3. Community Rehabilitation Center
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neurorehabilitation Market Size and Volume Forecast by Type
10.7.1. Brain Injury
10.7.2. Spinal Cord Injury
10.7.3. Peripheral Nerve Injury
10.7.4. Other
10.7.5. Neurorehabilitatio
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neurorehabilitation Demand Share Forecast, 2019-2026
11. Europe Neurorehabilitation Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neurorehabilitation Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neurorehabilitation Market Size and Volume Forecast by Application
11.4.1. General Hospital
11.4.2. Rehabilitation Specialist Hospital
11.4.3. Community Rehabilitation Center
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neurorehabilitation Market Size and Volume Forecast by Type
11.7.1. Brain Injury
11.7.2. Spinal Cord Injury
11.7.3. Peripheral Nerve Injury
11.7.4. Other
11.7.5. Neurorehabilitatio
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neurorehabilitation Demand Share, 2019-2026
12. Asia Pacific Neurorehabilitation Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neurorehabilitation Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neurorehabilitation Market Size and Volume Forecast by Application
12.4.1. General Hospital
12.4.2. Rehabilitation Specialist Hospital
12.4.3. Community Rehabilitation Center
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neurorehabilitation Market Size and Volume Forecast by Type
12.7.1. Brain Injury
12.7.2. Spinal Cord Injury
12.7.3. Peripheral Nerve Injury
12.7.4. Other
12.7.5. Neurorehabilitatio
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neurorehabilitation Demand Share, 2019-2026
13. Middle East & Africa Neurorehabilitation Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neurorehabilitation Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neurorehabilitation Market Size and Volume Forecast by Application
13.4.1. General Hospital
13.4.2. Rehabilitation Specialist Hospital
13.4.3. Community Rehabilitation Center
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neurorehabilitation Market Size and Volume Forecast by Type
13.7.1. Brain Injury
13.7.2. Spinal Cord Injury
13.7.3. Peripheral Nerve Injury
13.7.4. Other
13.7.5. Neurorehabilitatio
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neurorehabilitation Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neurorehabilitation Market: Market Share Analysis
14.2. Neurorehabilitation Distributors and Customers
14.3. Neurorehabilitation Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. VISHEE
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Beijing Bo'ai Hospital
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Beijing Rehabilitation Hospital of Capital Medical University
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. NCC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. CHIEFTAIN
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Tongji Hospital
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Haobro Medical Device
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. DIH
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sun Java
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Aoyang Health
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. PKUCare Rehabilitation Hospital
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Beijing Puhua International Hospital
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Xiangyu Medical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Beijing United Family Rehabilitation Hospital
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Neurorehabilitatio
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
